{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:43:50Z","timestamp":1792554230355,"version":"4.5.0"},"reference-count":58,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"abstract":"<jats:p>The placenta serves a critical role in nutrient uptake and waste elimination for the developing fetus. The placenta is also responsible for the uptake and\/or exchange of xenobiotics, including medications, between the maternal and fetal bloodstreams. An estimated 40\u201380% of women take medications or drugs during pregnancy. Very little is understood about fetal drug and nutrient exposure during pregnancy and how it may change over the course of fetal development. This study aimed to characterize the abundance of transport proteins in placental tissue, which are important in modulating fetal nutrient and drug exposure, over the duration of pregnancy. Using a mass spectrometry\u2010based global proteomic approach, the relative abundance of proteins in placental tissue samples was profiled from first trimester, second trimester, and term placenta samples. Our analysis detected a total of 6331 proteins which included a total of 139 solute carrier and ATP\u2010binding cassette transport proteins that were detected across the dataset, and 80 that were quantified in every sample. In general, membrane\u2010associated proteins, including solute carrier and ATP\u2010binding cassette transport proteins, were significantly enriched in placental tissue collected during early gestation compared to term placental tissue. Overall, this study presents a comprehensive profiling of membrane\u2010associated proteomic changes during gestation and identifies significant gestational age associated abundance changes at the protein level in several transport protein families. These data provide critical information to support future studies into the understanding of fetal exposure to xenobiotics and nutrients circulating in the maternal bloodstream.<\/jats:p>","DOI":"10.1002\/cpt.70525","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:32:27Z","timestamp":1792553547000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteomic Profiling of Xenobiotic and Nutrient Transporters in Human Placenta of Different Gestational Ages"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8873-1327","authenticated-orcid":false,"given":"Eric M.","family":"Weaver","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy University of Washington  Seattle Washington USA"},{"name":"University of Washington Transporter Elucidation Network University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8909-4685","authenticated-orcid":false,"given":"Ariel","family":"Topletz\u2010Erickson","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6534-9313","authenticated-orcid":false,"given":"Edward J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy University of Washington  Seattle Washington USA"},{"name":"University of Washington Transporter Elucidation Network University of Washington  Seattle Washington USA"},{"name":"Kidney Research Institute  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-9101","authenticated-orcid":false,"given":"Joanne","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy University of Washington  Seattle Washington USA"},{"name":"University of Washington Transporter Elucidation Network University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9548-3126","authenticated-orcid":false,"given":"Nina","family":"Isoherranen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-8455","authenticated-orcid":false,"given":"Jashvant D.","family":"Unadkat","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy University of Washington  Seattle Washington USA"},{"name":"University of Washington Transporter Elucidation Network University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-2347","authenticated-orcid":false,"given":"Samuel L.M.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy University of Washington  Seattle Washington USA"},{"name":"University of Washington Transporter Elucidation Network University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"e_1_2_10_1_1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","article-title":"Prescription and other medication use in pregnancy","volume":"131","author":"Haas D.M.","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2023.12.020","article-title":"Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence","volume":"231","author":"Mansour O.","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s43032-020-00173-y","article-title":"Changes in placental nutrient transporter protein expression and activity across gestation in Normal and obese women","volume":"27","author":"James\u2010Allan L.B.","year":"2020","journal-title":"Reprod. Sci."},{"key":"e_1_2_10_4_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2018.12.024","article-title":"Complex, coordinated and highly regulated changes in placental signaling and nutrient transport capacity in IUGR","volume":"1866","author":"Chassen S.","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s43032-021-00699-9","article-title":"Role of placental glucose transporters in determining fetal growth","volume":"29","author":"Joshi N.P.","year":"2022","journal-title":"Reprod. Sci."},{"key":"e_1_2_10_6_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313149","article-title":"Overview of drug transporters in human placenta","volume":"22","author":"Yamashita M.","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood\u2010placental barrier","volume":"158","author":"V\u00e4h\u00e4kangas K.","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel C.","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"e_1_2_10_9_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.crmeth.2022.100288","article-title":"Experimental reproducibility limits the correlation between mRNA and protein abundances in tumor proteomic profiles","volume":"2","author":"Upadhya S.R.","year":"2022","journal-title":"Cell Rep Methods"},{"key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/dmd.120.000067","article-title":"Gestational age\u2010dependent abundance of human placental transporters as determined by quantitative targeted proteomics","volume":"48","author":"Anoshchenko O.","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_10_11_1","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9189","article-title":"Discovery proteomics of human placental tissue","volume":"38","author":"Mellinger A.L.","year":"2023","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.placenta.2020.09.013","article-title":"Optimization of label\u2010free nano LC\u2010MS\/MS analysis of the placental proteome","volume":"101","author":"Luyten L.J.","year":"2020","journal-title":"Placenta"},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12014-022-09388-4","article-title":"A proteomic profile of the healthy human placenta","volume":"20","author":"Manna S.","year":"2023","journal-title":"Clin. Proteomics"},{"key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmsacl.2025.10.001","article-title":"Tear fluid proteomics: a comparative study of DIA and DDA mass spectrometry","volume":"38","author":"Ahmed S.","year":"2025","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mam.2012.12.009","article-title":"The ABCs of membrane transporters in health and disease (SLC series): introduction","volume":"34","author":"Hediger M.A.","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316789","article-title":"ABC transporters 45\u2009years on","volume":"24","author":"George A.M.","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/mas.21781","article-title":"Advances in data\u2010independent acquisition mass spectrometry towards comprehensive digital proteome landscape","volume":"42","author":"Kitata R.B.","year":"2023","journal-title":"Mass Spectrom. Rev."},{"key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1038\/s41598-019-40995-8","article-title":"Scaling in\u00a0vitro activity of CYP3A7 suggests human fetal livers do not clear retinoic acid entering from maternal circulation","volume":"9","author":"Topletz A.R.","year":"2019","journal-title":"Sci. Rep."},{"key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/AOG.0000000000002042","article-title":"Committee opinion No. 700 summary: methods for estimating the due date","volume":"129","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A\u2010dependent metabolism","volume":"283","author":"Paine M.F.","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1021\/acs.jproteome.7b00913","article-title":"Extending the compatibility of the SP3 paramagnetic bead processing approach for proteomics","volume":"17","author":"Moggridge S.","year":"2018","journal-title":"J. Proteome Res."},{"key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41597-023-02057-7","article-title":"A peptide\u2010centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer's disease","volume":"10","author":"Merrihew G.E.","year":"2023","journal-title":"Sci. Data"},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1074\/mcp.P119.001913","article-title":"Acquiring and analyzing data independent acquisition proteomics experiments without Spectrum libraries","volume":"19","author":"Pino L.K.","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"key":"e_1_2_10_24_1","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41467-020-15346-1","article-title":"Generating high quality libraries for DIA MS with empirically corrected peptide predictions","volume":"11","author":"Searle B.C.","year":"2020","journal-title":"Nat. Commun."},{"key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mas.21540","article-title":"The skyline ecosystem: informatics for quantitative mass spectrometry proteomics","volume":"39","author":"Pino L.K.","year":"2020","journal-title":"Mass Spectrom. Rev."},{"key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/bioinformatics\/btu305","article-title":"MSstats: an R package for statistical analysis of quantitative mass spectrometry\u2010based proteomic experiments","volume":"30","author":"Choi M.","year":"2014","journal-title":"Bioinformatics"},{"key":"e_1_2_10_27_1","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA\u2010sequencing and microarray studies","volume":"43","author":"Ritchie M.E.","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"e_1_2_10_28_1","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene\u2010set enrichment tool for animals and plants","volume":"36","author":"Ge S.X.","year":"2020","journal-title":"Bioinformatics"},{"key":"e_1_2_10_29_1","unstructured":"Blighe K.&Lun A.PCAtools: everything Principal Component Analysis(2019)."},{"key":"e_1_2_10_30_1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1074\/mcp.RA117.000543","article-title":"Panorama public: a public repository for quantitative data sets processed in skyline","volume":"17","author":"Sharma V.","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"e_1_2_10_31_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizca\u00edno J.A.","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"e_1_2_10_32_1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.placenta.2004.06.005","article-title":"Alphafetoprotein and alphafetoprotein receptor expression in the normal human placenta at term","volume":"26","author":"Newby D.","year":"2005","journal-title":"Placenta"},{"key":"e_1_2_10_33_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.placenta.2022.12.005","article-title":"Total alkaline phosphatase levels by gestational age in a large sample of pregnant women","volume":"132","author":"Titaux C.","year":"2023","journal-title":"Placenta"},{"key":"e_1_2_10_34_1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.xphs.2021.09.035","article-title":"Role of uptake transporters OAT4, OATP2A1, and OATP1A2 in human placental bio\u2010disposition of pravastatin","volume":"111","author":"Fokina V.M.","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"e_1_2_10_35_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101098","article-title":"Contribution of prostaglandin transporter OATP2A1\/SLCO2A1 to placenta\u2010to\u2010maternal hormone signaling and labor induction","volume":"23","author":"Inagaki M.","year":"2020","journal-title":"iScience"},{"key":"e_1_2_10_36_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.placenta.2016.02.010","article-title":"Protein expression of fatty acid transporter 2 is polarized to the trophoblast basal plasma membrane and increased in placentas from overweight\/obese women","volume":"40","author":"Lager S.","year":"2016","journal-title":"Placenta"},{"key":"e_1_2_10_37_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.acc.2017.12.006","article-title":"Distribution of fatty acids and lipids during pregnancy","volume":"84","author":"Chavan\u2010Gautam P.","year":"2018","journal-title":"Adv. Clin. Chem."},{"key":"e_1_2_10_38_1","first-page":"89","article-title":"Development of enzymes of glycolysis and gluconeogenesis in human fetal liver","volume":"62","author":"Sadava D.","year":"1992","journal-title":"Biol. Neonate"},{"key":"e_1_2_10_39_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/sp.2000.6360","article-title":"Gluconeogenesis in the fetus and neonate","volume":"24","author":"Kalhan S.","year":"2000","journal-title":"Semin. Perinatol."},{"key":"e_1_2_10_40_1","first-page":"1554","article-title":"Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation","volume":"77","author":"Jansson T.","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_2_10_41_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2018.12.010","article-title":"Human placental glucose transport in fetoplacental growth and metabolism","volume":"1866","author":"Illsley N.P.","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"e_1_2_10_42_1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.placenta.2011.09.014","article-title":"Glucose transporter 3 (GLUT3) protein expression in human placenta across gestation","volume":"32","author":"Brown K.","year":"2011","journal-title":"Placenta"},{"key":"e_1_2_10_43_1","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1053\/plac.2001.0639","article-title":"Nutrition of the human fetus during the first trimester\u2013a review","volume":"22","author":"Burton G.J.","year":"2001","journal-title":"Placenta"},{"key":"e_1_2_10_44_1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1042\/bj3150827","article-title":"Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons","volume":"315","author":"Maher F.","year":"1996","journal-title":"Biochem. J."},{"key":"e_1_2_10_45_1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/jdi.13680","article-title":"Placental expression of glucose transporters GLUT\u20101, GLUT\u20103, GLUT\u20108 and GLUT\u201012 in pregnancies complicated by gestational and type 1 diabetes mellitus","volume":"13","author":"Stanirowski P.J.","year":"2022","journal-title":"J Diabetes Investig"},{"key":"e_1_2_10_46_1","doi-asserted-by":"crossref","DOI":"10.3390\/cells13050391","article-title":"The impact of SLC2A8 RNA interference on glucose uptake and the transcriptome of human trophoblast cells","volume":"13","author":"Lipka A.","year":"2024","journal-title":"Cells"},{"key":"e_1_2_10_47_1","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1210\/clinem\/dgaa814","article-title":"Placental inositol reduced in gestational diabetes as glucose alters inositol transporters and IMPA1 enzyme expression","volume":"106","author":"Pillai R.A.","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_2_10_48_1","doi-asserted-by":"crossref","first-page":"C1077","DOI":"10.1152\/ajpcell.2001.281.4.C1077","article-title":"Function and structure of heterodimeric amino acid transporters","volume":"281","author":"Wagner C.A.","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"e_1_2_10_49_1","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.placenta.2012.05.010","article-title":"The emerging role of mTORC1 signaling in placental nutrient\u2010sensing","volume":"33","author":"Jansson T.","year":"2012","journal-title":"Placenta"},{"key":"e_1_2_10_50_1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/jcmm.13966","article-title":"Gestational age\u2010dependent gene expression profiling of ATP\u2010binding cassette transporters in the healthy human placenta","volume":"23","author":"Imperio G.E.","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"e_1_2_10_51_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","article-title":"Membrane transporters in drug development and as determinants of precision medicine","volume":"23","author":"Galetin A.","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"e_1_2_10_52_1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/dmd.121.000538","article-title":"Successful prediction of human fetal exposure to P\u2010glycoprotein substrate drugs using the proteomics\u2010informed relative expression factor approach and PBPK modeling and simulation","volume":"49","author":"Anoshchenko O.","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_10_53_1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cpt.3157","article-title":"Successful prediction of fetal exposure to dual BCRP\/P\u2010gp drug substrates using the efflux ratio\u2010relative expression factor approach and PBPK M&S","volume":"115","author":"Balhara A.","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_10_54_1","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/jcph.2117","article-title":"Predicting human fetal drug exposure through maternal\u2010fetal PBPK modeling and in\u00a0vitro or ex\u00a0vivo studies","volume":"62","author":"Balhara A.","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"e_1_2_10_55_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11597440-000000000-00000","article-title":"Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling","volume":"51","author":"Abduljalil K.","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"e_1_2_10_56_1","article-title":"A PBPK model to predict disposition of CYP3A\u2010metabolized drugs in pregnant women: verification and discerning the site of CYP3A induction","volume":"1","author":"Ke A.B.","year":"2012","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"e_1_2_10_57_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bcp.12207","article-title":"Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19","volume":"77","author":"Ke A.B.","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_2_10_58_1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/dmd.116.073957","article-title":"Development of a novel maternal\u2010fetal physiologically based pharmacokinetic model II: verification of the model for passive placental permeability drugs","volume":"45","author":"Zhang Z.","year":"2017","journal-title":"Drug Metab. Dispos."}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70525","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.70525","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:32:35Z","timestamp":1792553555000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.70525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":58,"alternative-id":["10.1002\/cpt.70525"],"URL":"https:\/\/doi.org\/10.1002\/cpt.70525","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"2026-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"cpt.70525"}}